PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety check for COPD-related heart-lung drug
Disease control TerminatedThis study aimed to check the long-term safety of an inhaled medication called treprostinil for people with both chronic obstructive pulmonary disease (COPD) and high blood pressure in their lungs. It was an extension study for 41 participants who had already completed a previous…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tiny Heart-Lung drug trial halted after just 4 patients
Disease control TerminatedThis early study tested an experimental drug called HS135 in obese patients with two related conditions: heart failure where the heart pumps normally but doesn't fill properly, and high blood pressure in the lungs. Only 4 people were enrolled before the study was stopped. The mai…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC